Home
About Us
Covid-19
NRX-100/101
News
Contact
Home
News
Broadcasts
Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial
Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial
Broadcasts
June 15, 2020
August 5, 2020
Related Posts
Press releases
October 13, 2020
October 13, 2020
NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100™ (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19
Read more
News
August 5, 2020
August 6, 2020
Which COVID-19 treatments are showing promise? A list of potential drugs
Read more
Press releases
September 23, 2020
September 23, 2020
NeuroRx submits request for Emergency Use Authorization for RLF-100™ (aviptadil) in the treatment of patients with Critical COVID-19 and Respiratory Failure who have exhausted approved therapy
Read more
